You are here:

Symptom Management Clinical Trials

 

Study Name:

A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium in Two Different Versions to Prevent Oxaliplatin-Induced Sensory Neurotoxicity 

 

         

Purpose:

This randomized phase III trial is studying different administration schedules of calcium gluconate and magnesium sulfate and comparing how well they work in neurotoxicity in patients with colon cancer rectal cancer receiving oxaliplatin-based combination chemotherapy. 

Study Type: Treatment

Protocol: UIC 2010-0865 N08CB

 

 For study details, click here.

Internal users only: click here for protocol details and forms.

Study Name:

A Randomized, Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer.

 

 

         

Purpose:

This randomized phase III trial is studying two different schedules of zoledronic acid to compare how well they work in treating patients with metastatic breast cancer, metastatic prostate cancer, or multiple myeloma with bone involvement.

 

Study Type: Treatment

Protocol: UIC 2010-0585 CALGB-70604

 

 For study details, click here.

Internal users only: click here for protocol details and forms.

Back to Oncology Clinical Trials Homepage